基石科技控股(08391.HK)主要股東售股及變更
基石科技控股(08391.HK)公佈,彩貝已出售而李民強已購買冠雙全部已發行股份。目前冠雙擁有公司股份中8,100萬股權益,相當於已發行股本約13.3%。
於轉讓前,冠雙由彩貝直接全資擁有,並由蘇永強間接全資擁有。於轉讓事項完成後,彩貝及蘇永強不再於冠雙持有之股份中擁有任何權益,並不再爲公司主要股東。
公司指,李民強爲執行董事。於轉讓事項完成後,他實益擁有591.26萬股股份,並透過冠雙及Tanner Enterprises Group Limited於9,420萬股股份中擁有權益。目前他合共於1億股股份,佔公司已發行股本總額約16.5%中擁有權益,因此成爲公司主要股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.